BIT 0.00% 2.2¢ biotron limited

MSB is worth significantly more, it has completed its phase 3...

  1. 70 Posts.
    lightbulb Created with Sketch. 2
    MSB is worth significantly more, it has completed its phase 3 trials and is waiting on FDA approval, and has other phase 2/3 ongoing hence the finish line is closer. That said I hold both and think in the long term both will be valued at significantly more than their current MC
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.